CLINICAL TRIAL PATIENT TECHNOLOGY INSIGHTS
-
Edge AI Is Reshaping How Clinical Trials Run
Edge computing and AI are transforming clinical trials – enabling real time monitoring, decentralized research, and faster, more cost-effective drug development.
-
Telehealth In Clinical Trials: What Sites And Patients Think
Sites and patients have complicated views on telehealth in trials. Here’s what the evidence shows about who benefits, who bears the burden, and where the limits are.
ECOA RESOURCES
-
Listen to what sites have to say about the changing nature of COAs in clinical trials, including the usage of eCOA, its benefits, and ways to improve the technology.
-
Download this guide for five key recommendations on how to build an eCOA strategy in your next oncology trial that keeps your patient's voice front and center in their care.
-
With more than 76% of sponsors seeking to implement decentralized solutions this year, there’s never been more attention given to decentralized trials. Discover why decentralized trials must take a unified approach, one that alleviates burdens for patients and sites in order to drive cost savings and realize efficiencies.
ECONSENT RESOURCES
-
With more than 76% of sponsors seeking to implement decentralized solutions this year, there’s never been more attention given to decentralized trials. Discover why decentralized trials must take a unified approach, one that alleviates burdens for patients and sites in order to drive cost savings and realize efficiencies.
-
Digital and DCT elements like eCOA, platforms, and wearables have transformed the ways we conduct clinical research. Read through the latest industry analysis and data on the real impacts these technologies have on clinical trials with this new ebook.
-
By dispelling prevalent misconceptions regarding participant age, cost, and complexity, see how this platform emerged as a versatile, rapid, and effective solution tailored to the unique needs of the elderly renal care population.
EPRO RESOURCES
-
With more than 76% of sponsors seeking to implement decentralized solutions this year, there’s never been more attention given to decentralized trials. Discover why decentralized trials must take a unified approach, one that alleviates burdens for patients and sites in order to drive cost savings and realize efficiencies.
-
Discover how the interview mode constitutes an additional data entry mode for ePROs when clinical trial participants cannot go to the study site for a scheduled visit.
-
Willie Muehlhausen, Co-CEO and Founder of Safira Clinical Research, and Tim Davis, VP of Strategy at MyVeeva for Patients, discuss how ePRO delivery needs to change to better serve modern trials.